Cooley advised Vivace Therapeutics, Inc., and Wilson Sonsini Goodrich & Rosati advised Vivace Therapeutics on the patent matters related to the transaction.Vivace Therapeutics, Inc. announced the…
Vivace Therapeutics’ $35 Million Series D Financing Round
